ClinConnect ClinConnect Logo
Search / Trial NCT03929731

Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)

Launched by SINGAPORE NATIONAL EYE CENTRE · Apr 26, 2019

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the long-term outcomes of a condition called Polypoidal Choroidal Vasculopathy (PCV). Researchers want to find out how often PCV comes back after treatment, what kind of treatments patients need, and whether closing the abnormal blood vessels in the eye within the first year leads to better vision in the long run. They will also look into how likely it is for the other eye to develop this condition.

To participate in this study, individuals must have previously taken part in certain PCV clinical trials and be able to provide consent for this follow-up. There are no strict exclusion criteria, so as long as someone meets the inclusion requirements, they can join. Participants can expect to share their experiences and outcomes regarding their PCV treatment over the past five years, helping doctors better understand this condition and improve future care for others.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants will have completed the previous PCV RCTs: EVEREST II, PLANET and PCV T\&E studies
  • Are able to give consent for this follow up study
  • Exclusion Criteria:
  • No exclusion criteria unless they do not meet the inclusion criteria

About Singapore National Eye Centre

The Singapore National Eye Centre (SNEC) is a premier institution dedicated to advancing ophthalmic care through innovative research and clinical excellence. As a leading clinical trial sponsor, SNEC focuses on improving the diagnosis and treatment of a wide range of eye conditions, leveraging cutting-edge technologies and methodologies. Committed to enhancing patient outcomes, SNEC collaborates with a network of healthcare professionals and researchers to conduct rigorous clinical trials that contribute to the global understanding of ocular health. Their comprehensive approach integrates patient care with scientific inquiry, ensuring that advancements in eye care are both evidence-based and aligned with the needs of the community.

Locations

Singapore, , Singapore

Singapore, , Singapore

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Principal Investigator

Principal Investigator

Singapore National Eye Centre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials